Article
Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy
15 Feb 2018
Abstract excerpt
transgene (AAV9/JeT-GAN) currently employed in the clinical trial. Treatment with AAV/JeT-GAN restored the normal configuration of IFs in patient fibroblasts within days in cell culture and by 4 weeks in GAN KO mice. IT delivery of AAV9/JeT-GAN in aged GAN KO mice preserved sciatic nerve ultrastructure, reduced neuronal IF accumulations and attenuated rotarod dysfunction. This strategy conferred sustained...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
